share_log

藥明康德：2023年股東週年大會通告

WUXI APPTEC: NOTICE OF THE ANNUAL GENERAL MEETING OF 2023

Hong Kong Stock Exchange ·  May 9 18:46
Summary by Futu AI
药明康德（股份代號：2359）將於2024年6月12日在上海外高橋喜來登酒店召開2023年股東週年大會。會議將審議多項普通決議案，包括批准2023年度董事會、監事會工作報告、財務決算報告，以及利潤分配方案等。此外，還將審議關於對外擔保、外匯套期保值業務額度、關聯交易管理制度等事項的修訂提案。會議還將涉及2024年H股獎勵信託計劃的採納及相關授權事宜。特別決議案則包括公司註冊資本變更、股東大會議事規則修訂等。股東將對發行A股及╱或H股的一般授權以及回購A股及╱或H股的一般授權進行考慮。會議結果將按照《上市規則》公布於香港聯交所及公司網站。
药明康德（股份代號：2359）將於2024年6月12日在上海外高橋喜來登酒店召開2023年股東週年大會。會議將審議多項普通決議案，包括批准2023年度董事會、監事會工作報告、財務決算報告，以及利潤分配方案等。此外，還將審議關於對外擔保、外匯套期保值業務額度、關聯交易管理制度等事項的修訂提案。會議還將涉及2024年H股獎勵信託計劃的採納及相關授權事宜。特別決議案則包括公司註冊資本變更、股東大會議事規則修訂等。股東將對發行A股及╱或H股的一般授權以及回購A股及╱或H股的一般授權進行考慮。會議結果將按照《上市規則》公布於香港聯交所及公司網站。
Pharmaceutical Ming Kand (stock code: 2359) will hold its 2023 Annual General Meeting on 12 June 2024 at the Sheraton Takahashi Hotel, Shanghai. The meeting will consider a number of ordinary resolutions, including the approval of the 2023 Board of Directors, the Board of Supervisors work report, the financial report, and the profit distribution plan, etc. In addition, amendments will be considered on issues related to external guarantees, FX hedging value, the associated transaction management system, etc. The meeting will also cover the adoption and related authorization of the H Share Award Trust Scheme 2024. Special resolutions include changes in the registered capital of companies, amendments to the rules for general meetings, etc. Shareholders will consider the general authorization to issue A shares and/or H shares and the general authorization to repurchase A shares and/or H shares. The results of the meeting will be published in accordance with the Listing Rules on the HKEx and the Company's website.
Pharmaceutical Ming Kand (stock code: 2359) will hold its 2023 Annual General Meeting on 12 June 2024 at the Sheraton Takahashi Hotel, Shanghai. The meeting will consider a number of ordinary resolutions, including the approval of the 2023 Board of Directors, the Board of Supervisors work report, the financial report, and the profit distribution plan, etc. In addition, amendments will be considered on issues related to external guarantees, FX hedging value, the associated transaction management system, etc. The meeting will also cover the adoption and related authorization of the H Share Award Trust Scheme 2024. Special resolutions include changes in the registered capital of companies, amendments to the rules for general meetings, etc. Shareholders will consider the general authorization to issue A shares and/or H shares and the general authorization to repurchase A shares and/or H shares. The results of the meeting will be published in accordance with the Listing Rules on the HKEx and the Company's website.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.